Quantcast

SLIDESHOW

ACG New York Women of Leadership - Entrepreneur Series
Barbara Bradley Baekgaard, founder of Vera Bradley (Nasdaq: VRA), is the latest in a series of entrepreneurs highlighted at ACG New York Women of Leadership events. Photo credit: Robert Blumenfeld

Watercooler

GTCR, Hormel, the Riverside Co-CEOs and Others Win M&A Mid-Market Awards
Amid a slow and challenging year for dealmaking, the winners of Mergers & Acquisitions’ 7th Annual M&A Mid-Market Awards outpaced the competition to grow, innovate and lead the middle market

Roundtable

Financial Services Companies Heat Up M&A Market
Speakers from Flexpoint Ford, Genstar Capital, Baird Capital, Madison Capital Funding and Katten Muchin Rosenman discuss the various factors playing a role in M&A activity within the financial services space

Expert's Corner

Pursuing Pharma Manufacturing
The fragmented pharmaceutical manufacturing industry provides plenty of opportunities for private equity investors, says JLL Partners founder Paul Levy

Today’s Transactions:
Merit Medical the Latest to Buy a Catheter Company

Following Boston Scientific’s lead, Merit Medical buys Thomas Medical from GE Healthcare

Merit Medical Systems Inc. (Nasdaq: MMSI) will acquire Thomas Medical Products Inc. from GE Healthcare for $167 million.

Thomas Medical, headquartered in Malvern, Pa., makes catheter-based vascular devices. South Jordan, Utah-based Merit makes and markets disposable supplies used in cardiology, radiology and endoscopy.

Merit will complete the deal through an expansion of its credit facility from Wells Fargo Bank to $275 million.

Piper Jaffray & Co. served as Merit’s financial adviser and offered a fairness opinion to Merit’s board of directors, Raymond James Financial Inc. also provided an opinion to the board, and Parr Brown Gee & Loveless served as the company’s legal adviser. Moelis & Co. LLC served as GE’s financial adviser, while Paul Hastings LLP served as legal counsel.

The deal was announced on the heals of two other acquisitions that centered on catheter technology. Boston Scientific Corp. (NYSE: BSX), a Natick, Mass.-based medical device manufacturer, paid $125 million for Vessix Vascular Inc. about one month after it spent $265 million for Rhythmia Medical Inc.

 

For more information on related topics, visit the following: